Bristol-Myers, Oncothyreon Are Big Market Movers

June 1, 2015 8:22 PM

68 0

The drug developer presented promising data on a skin cancer treatment, along with a positive FDA regulatory announcement.

The industrial company is being taken private in a sale to private-equity firm Apollo Global Management LLC for about $1 billion.

Read more

To category page